HardOn Oral Jelly Research Overview
HardOn Oral Jelly is a phosphodiesterase type 5 (PDE5) inhibitor containing sildenafil citrate in a flavoured gel formulation. This laboratory-grade compound from Aurochem Pharmaceuticals enables researchers to investigate PDE5 enzyme inhibition mechanisms and cyclic GMP pathway modulation in controlled experimental settings. The oral jelly format provides an alternative research model to traditional tablet formulations, allowing scientists to examine bioavailability characteristics and dissolution profiles in laboratory environments. Researchers studying cardiovascular pharmacology and enzyme inhibition pathways frequently utilise sildenafil citrate compounds to understand vasodilation mechanisms and smooth muscle relaxation processes.
Research Applications and Studies
Laboratory investigations with sildenafil citrate examine its selective inhibition of phosphodiesterase type 5 enzymes, which regulate cyclic guanosine monophosphate degradation in smooth muscle cells. Research protocols evaluate the compound’s binding affinity to PDE5 active sites and subsequent effects on nitric oxide signalling pathways. Scientists at Stroid UK Shop utilise these compounds alongside other research chemicals from our SARMs collection and peptides range to investigate various biochemical pathways. The flavoured jelly formulation allows researchers to study absorption kinetics and pharmacological profiles different from conventional solid dosage forms. Cardiovascular research laboratories frequently examine sildenafil’s effects on pulmonary arterial pressure and vascular smooth muscle function. Comprehensive studies available through our sildenafil citrate research category demonstrate the compound’s utility in understanding PDE enzyme selectivity and tissue-specific responses in experimental models.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Concentration | 100mg per unit |
| Formulation | Flavoured Oral Jelly |
| Manufacturer | Aurochem Pharmaceuticals |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Storage Requirements | Room temperature, dry conditions |
| Research Grade | Laboratory standard |
Compliance and Research Use
HardOn Oral Jelly is supplied exclusively for in-vitro research applications and laboratory studies examining PDE5 inhibition mechanisms. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols when handling sildenafil citrate compounds and maintain appropriate storage conditions to preserve compound integrity. All investigations should follow institutional guidelines for research chemical handling and disposal. Purchase requires verification of legitimate research purposes and appropriate laboratory facilities.
